Novartis AG Current Ratio 2006-2020 | NVS

Current and historical current ratio for Novartis AG (NVS) from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Novartis AG current ratio for the three months ending June 30, 2020 was 0.81.
Novartis AG Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-06-30 $23.88B $29.38B 0.81
2020-03-31 $23.10B $31.29B 0.74
2019-12-31 $29.50B $28.26B 1.04
2019-09-30 $26.68B $28.22B 0.95
2019-06-30 $28.32B $30.11B 0.94
2019-03-31 $52.45B $56.13B 0.93
2018-12-31 $35.56B $29.61B 1.20
2018-09-30 $34.11B $28.33B 1.20
2018-06-30 $32.07B $27.94B 1.15
2018-03-31 $33.05B $28.22B 1.17
2017-12-31 $28.21B $23.40B 1.21
2017-09-30 $27.47B $25.38B 1.08
2017-06-30 $26.54B $26.15B 1.02
2017-03-31 $25.77B $26.33B 0.98
2016-12-31 $24.93B $22.21B 1.12
2016-09-30 $25.88B $24.60B 1.05
2016-06-30 $23.72B $26.27B 0.90
2016-03-31 $22.99B $27.82B 0.83
2015-12-31 $22.85B $23.71B 0.96
2015-09-30 $24.05B $28.16B 0.85
2015-06-30 $24.75B $29.39B 0.84
2015-03-31 $25.71B $29.05B 0.89
2014-12-31 $37.56B $26.97B 1.39
2014-09-30 $36.79B $26.62B 1.38
2014-06-30 $34.97B $27.56B 1.27
2014-03-31 $29.69B $24.76B 1.20
2013-12-31 $30.54B $26.37B 1.16
2013-09-30 $28.77B $25.81B 1.12
2013-06-30 $26.85B $24.39B 1.10
2013-03-31 $26.80B $26.37B 1.02
2012-12-31 $28.00B $24.05B 1.16
2012-09-30 $26.15B $21.86B 1.20
2012-06-30 $26.12B $24.92B 1.05
2012-03-31 $25.79B $27.36B 0.94
2011-12-31 $24.08B $23.15B 1.04
2011-09-30 $25.56B $25.83B 0.99
2011-06-30 $26.63B $29.54B 0.90
2011-03-31 $29.10B $32.22B 0.90
2010-12-31 $26.69B $24.66B 1.08
2010-09-30 $27.72B $27.66B 1.00
2010-06-30 $38.67B $17.83B 2.17
2010-03-31 $35.80B $17.43B 2.05
2009-12-31 $33.69B $19.47B 1.73
2009-09-30 $30.44B $17.90B 1.70
2009-06-30 $27.17B $15.36B 1.77
2009-03-31 $22.48B $14.99B 1.50
2008-12-31 $20.88B $16.50B 1.27
2008-09-30 $23.30B $19.95B 1.17
2008-06-30 $32.09B $19.68B 1.63
2008-03-31 $26.29B $17.06B 1.54
2007-12-31 $27.43B $16.64B 1.65
2007-09-30 $28.68B $17.50B 1.64
2007-06-30 $23.98B $17.66B 1.36
2007-03-31 $21.33B $17.55B 1.22
2006-12-31 $21.40B $16.23B 1.32
2006-09-30 $20.97B $16.32B 1.29
2006-06-30 $19.80B $16.76B 1.18
2006-03-31 $21.92B $15.59B 1.41
2005-12-31 $21.44B $15.33B 1.40
2005-09-30 $18.48B $12.35B 1.50
2005-06-30 $20.11B $12.54B 1.60
2005-03-31 $22.26B $11.22B 1.99
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $189.756B $47.498B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.238B 18.65
Roche Holding AG (RHHBY) Switzerland $294.553B 0.00
Pfizer (PFE) United States $213.662B 13.35
Merck (MRK) United States $204.919B 14.63
AbbVie (ABBV) United States $163.988B 9.99
Novo Nordisk (NVO) Denmark $152.214B 24.77
Eli Lilly (LLY) United States $146.273B 22.33
AstraZeneca (AZN) United Kingdom $145.417B 28.27
Sanofi (SNY) $128.988B 15.33
GlaxoSmithKline (GSK) United Kingdom $102.323B 13.42
Bayer (BAYRY) Germany $61.403B 8.85
H Lundbeck (HLUYY) Denmark $7.388B 0.00
Innoviva (INVA) United States $1.370B 6.56